L C PHARMA
DEAD

Serial Number

78247221

Owner

LIFE CYCLE PHARMA A/S

Attorney

Kelly L. Williams

Filing Date

May 8, 2003

Add to watchlist:

No watchlists yet
View on USPTO

L C PHARMA Trademark

Serial Number: 78247221

L C PHARMA is a trademark filed by LIFE CYCLE PHARMA A/S on May 8, 2003. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

LIFE CYCLE PHARMA A/S (2 trademarks)

KOGLE ALLE 4
DK-2970 HORSHOOLM , DK

Entity Type: 03

Pharotech A/S (6 trademarks)

Ottiliavej 9
Valby 2500 , DK

Entity Type: 03

Trademark Details

Filing Date

May 8, 2003

Registration Date

Not Registered

Published for Opposition

March 1, 2005

Goods & Services

Educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fields

Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations, solutions, for use in the pharmaceutical and medical industries

Pharmaceutical preparations; medical preparations; and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, granules, pills, sachets, powders, and capsules; all of the above for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised pain

Scientific research within the medical, pharmaceutical, biotechnical and bacteriological areas and providing consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; preparation of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; and materials testing for the pharmaceutical and medical industries.

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 23, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 23, 2006 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 24, 2005 NOAM
PUBLISHED FOR OPPOSITION
Mar 1, 2005 PUBO
NOTICE OF PUBLICATION
Feb 9, 2005 NPUB
PAPER RECEIVED
Dec 29, 2004 MAIL
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 23, 2004 PREV
ASSIGNED TO LIE
Nov 22, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 17, 2004 CNSA
AMENDMENT FROM APPLICANT ENTERED
Sep 29, 2004 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2004 TROA
FINAL REFUSAL E-MAILED
Mar 20, 2004 GNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2004 CRFA
PAPER RECEIVED
Feb 19, 2004 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 17, 2004 TCCA
NON-FINAL ACTION E-MAILED
Oct 19, 2003 GNRT
ASSIGNED TO EXAMINER
Oct 19, 2003 DOCK